HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)
Clinical trial NCT02806505 · COMPLETED
Trial details
- NCT number
- NCT02806505
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2007-08-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.